Amarin Corp Plc (AMRN)

[rosemountbomber]

I guess I would say that if sales here in the US are dropping faster than sales are picking up in the ROW, then the road points to that outcome.  Of course we think that eventually ROW should replace US sales, but that eventually seems to be coming at a snail's pace. The cash situation at end of qtr 3 looked good partly because they included a 15m payment received.  I just got my 2025 BCBS formulary and Vascepa is not on it.  What if more insurers follow BCBS and CVS, etc., and drop V?  They must be worried to some degree about cash/business for them not to have initiated some BB.